医療用フットウェアの世界市場規模、シェア、動向分析レポート：最終用途別、流通チャネル別、地域別、セグメント別予測（2025年～2030年）

医療用フットウェア市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の医療用フットウェアの市場規模は、2030年までに182億8,000万米ドルに達し、2025年～2030年のCAGRは11.1％で拡大すると予測されています。

足に関連する問題、足首の捻挫、潰瘍、糖尿病、肥満による負担や足の痛みの症例の増加が、この市場の成長を促進すると予想されています。米国足病医学協会（APMA）によると、2018年には、肥満者の81％近くが、太りすぎによる足の痛みや複数の足や足首の障害を経験していることを認めています。

男性セグメントが市場をリードし、2019年の世界売上高の57.2％のシェアを占めました。技術革新と製品発売の増加が医療用フットウェアの需要を牽引しています。例えば、2019年、Footwear Unlimited, Inc.ブランドのBaretrapsは、着用者が姿勢を正し、膝、つま先、足首への負担や圧力を軽減するのに役立つPosture+技術を搭載した快適な靴を発表しました。この靴には、サポート力のあるヒールカップと、足の痛みを軽減する装具が内蔵されています。

女性用セグメントは、2020年～2027年に最も速いCAGR5.9％を記録すると予想されます。メーカーは、女性用のカジュアルな外観の靴を発売することで製品ポートフォリオを広げており、これがセグメントの成長を促進しています。例えば、2019年7月、医療用フットウェアブランドのDr.Comfortは、フルグレインレザーを使用し、耐久性、安定性、サポートを補助するために、縫い目の線を減らし、保護トゥボックス、安定したアウトソール、取り外し可能なアウトソール、摩耗防止素材を備えたアスレジャースタイルの靴「The Ruth」を女性用カテゴリーで発売しました。

COVID-19（コロナウイルス）の流行は、医療用フットウェアを含むフットウェア業界に深刻な影響を与え、店舗の閉鎖、ロックダウン措置、世界レベルでの輸出入の制限により需要が減少しています。2020年2月中旬～3月中旬にAmazonで発表された売上データによると、フットウェアの売上は平均40ポイント減少しました。消費者は消費習慣をより意識するようになり、必需品を中心に購入する傾向にあり、これは市場にとって大きな課題となっています。

予測期間中、最も急成長が見込まれるのはオンライン流通チャネルです。メーカーの間でeコマース・チャネルの人気が高まっていることと、ミレニアル世代、Z世代、X世代におけるインターネット普及率の高さが、このチャネルを通じた販売を促進しています。Amazon、Flipkart、Orthorest、Dr. Comfortのようなeコマースサイトは、割引、お得な情報、新発売を提供し、消費者を引き付けています。

北米は医療用フットウェア市場を独占し、2019年の世界売上高の33.5％のシェアを占めました。同地域市場の成長の原動力は、同地域で足関連の問題を経験する人の増加です。米国足病医学協会の報告書によると、米国人の50％が、デザインの悪い靴やジャンプ、ランニング、ダンスなどの衝撃の強い活動で起こる足の痛みのために屋外活動を制限しています。

アジア太平洋は、2020年～2027年に最も速いCAGR6.1％を記録すると予想されています。この地域では糖尿病の患者が増加しており、医療用フットウェアの需要を牽引すると予想されます。さらに、中国、インド、日本を含む国々の人々は健康に対する意識が高まっており、慢性的な足の痛みを緩和できるフットウェアを進んで購入しています。

医療用フットウェア市場レポートのハイライト

• オンライン販売チャネルは2024年に最速の販売チャネルとして台頭し、予測期間を通じてリードを維持すると予想されます。さまざまなブランドの医療用フットウェアが入手しやすくなっていること、無料配送、電子小売業者のプラットフォームにおける季節割引などが、同セグメントの成長に拍車をかけています。
• 男性セグメントは、糖尿病や整形外科疾患などの男性における足関連の問題の有病率の増加により、2024年に医療用フットウェア産業で最大の収益シェアを占めました。
• アジア太平洋は、2024年～2030年のCAGRが6.1%で、最も急成長している地域市場です。血流の増加、可動性の向上、足のサポートの強化など、医療用フットウェアの利点に関する人々の意識の高まりが、この地域市場を牽引すると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 医療用フットウェア市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連市場見通し
• 業界バリューチェーン分析
  • 利益率分析（業界レベル）
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 市場機会
  • 市場の課題
• 業界分析ツール
  • ポーターのファイブフォース分析
• 市場参入戦略

第4章 消費者行動分析

• 人口統計分析
• 消費者の動向と嗜好
• 購入決定に影響を与える要因
• 消費者製品の採用
• 観察と推奨事項

第5章 医療用フットウェア市場：流通チャネルの推定・動向分析

• 医療用フットウェア市場：流通チャネル別、重要なポイント
• 流通チャネルの変動分析と市場シェア（2024年・2030年）
• 流通チャネル別（2018年～2030年）
  • オフライン
  • オンライン

第6章 医療用フットウェア市場：最終用途の推定・動向分析

• 医療用フットウェア市場：最終用途別、主なポイント
• 最終用途の変動分析と市場シェア（2024年・2030年）
• 最終用途別（2018年～2030年）
  • 男性
  • 女性

第7章 医療用フットウェア市場：地域の推定・動向分析

• 医療用フットウェア市場：地域別展望
• 地域市場：重要なポイント
• 地域別（2018年～2030年）
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第8章 医療用フットウェア市場：競合分析

• 主要市場参入企業による最近の動向と影響分析
• 企業分類
• 参入企業の概要
• 財務実績
• 製品ベンチマーク
• 企業ヒートマップ分析
• 戦略マッピング
• 企業プロファイル
  • DJO, LLC
  • New Balance
  • Dr. Zen's.
  • Gravity Defyer Corp.
  • Orthofeet Inc
  • Aetrex Inc.
  • DARCO International, Inc.
  • Dr. Foot Inc.
  • Duna
  • Mephisto

List of Tables

• Table 1 Global medical footwear market: Key market driver analysis
• Table 2 Global medical footwear market: Key market restraint analysis
• Table 3 Global medical footwear market estimates & forecast, by distribution channel (USD Million)
• Table 4 Global medical footwear market estimates & forecast, by end use (USD Million)
• Table 5 North America medical footwear market estimates and forecast, by country, 2018 - 2030 (USD Million)
• Table 6 North America medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
• Table 7 North America medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
• Table 8 U.S. macro-economic outlay
• Table 9 U.S. medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
• Table 10 U.S. medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
• Table 11 Canada macro-economic outlay
• Table 12 Canada medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
• Table 13 Canada medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
• Table 14 Mexico macro-economic outlay
• Table 15 Mexico medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
• Table 16 Mexico medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
• Table 17 Europe medical footwear market estimates and forecast, by country, 2018 - 2030 (USD Million)
• Table 18 Europe medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
• Table 19 Europe medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
• Table 20 UK macro-economic outlay
• Table 21 UK medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
• Table 22 UK medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
• Table 23 Germany macro-economic outlay
• Table 24 Germany medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
• Table 25 Germany medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
• Table 26 France macro-economic outlay
• Table 27 France medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
• Table 28 France medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
• Table 29 Italy macro-economic outlay
• Table 30 Italy medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
• Table 31 Italy medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
• Table 32 Spain macro-economic outlay
• Table 33 Spain medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
• Table 34 Spain medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
• Table 35 Asia Pacific medical footwear market estimates and forecast, by country, 2018 - 2030 (USD Million)
• Table 36 Asia Pacific medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
• Table 37 Asia Pacific medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
• Table 38 China macro-economic outlay
• Table 39 China medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
• Table 40 China medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
• Table 41 India macro-economic outlay
• Table 42 India medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
• Table 43 India medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
• Table 44 Japan macro-economic outlay
• Table 45 Japan medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
• Table 46 Japan medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
• Table 47 Australia macro-economic outlay
• Table 48 Australia medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
• Table 49 Australia medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
• Table 50 South Korea macro-economic outlay
• Table 51 South Korea medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
• Table 52 South Korea medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
• Table 53 Latin America medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
• Table 54 Latin America medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
• Table 55 Brazil macro-economic outlay
• Table 56 Brazil medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
• Table 57 Brazil medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
• Table 58 Middle East & Africa medical footwear market estimates and forecast, by country, 2018 - 2030 (USD Million)
• Table 59 Middle East & Africa medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
• Table 60 Middle East & Africa medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
• Table 61 Recent developments & impact analysis, by key market participants
• Table 62 Company heat map analysis, 2024
• Table 63 Companies implementing key strategies

List of Figures

• Fig. 1 Medical footwear market segmentation
• Fig. 2 Information procurement
• Fig. 3 Primary research pattern
• Fig. 4 Primary research approaches
• Fig. 5 Primary research process
• Fig. 6 Market snapshot
• Fig. 7 Segment snapshot
• Fig. 8 Regional snapshot
• Fig. 9 Competitive landscape snapshot
• Fig. 10 Global parent industry and medical footwear size (USD Million)
• Fig. 11 Global medical footwear size, 2018 to 2030 (USD Million)
• Fig. 12 Medical footwear market: Penetration & growth prospect mapping
• Fig. 13 Medical footwear market: Value chain analysis
• Fig. 14 Medical footwear market: Dynamics
• Fig. 15 Medical footwear market: Porter's five forces analysis
• Fig. 16 Medical footwear market estimates & forecast, by distribution channel (USD Million)
• Fig. 17 Medical footwear market estimates & forecasts for offline, 2018 - 2030 (USD Million)
• Fig. 18 Medical footwear market estimates & forecasts for online, 2018 - 2030 (USD Million)
• Fig. 19 Medical footwear market estimates & forecast, by end use (USD Million)
• Fig. 20 Men medical footwear market estimates & forecasts, 2018 - 2030 (USD Million)
• Fig. 21 Women medical footwear market estimates & forecasts, 2018 - 2030 (USD Million)
• Fig. 22 Medical footwear market: Regional outlook, 2024 & 2030 (USD Million)
• Fig. 23 Regional marketplace: Key takeaways
• Fig. 24 North America medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
• Fig. 25 U.S. medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
• Fig. 26 Canada medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
• Fig. 27 Mexico medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
• Fig. 28 Europe medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
• Fig. 29 Germany medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
• Fig. 30 UK medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
• Fig. 31 France medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
• Fig. 32 Italy medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
• Fig. 33 Spain medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
• Fig. 34 Asia Pacific medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
• Fig. 35 China medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
• Fig. 36 India medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
• Fig. 37 Japan medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
• Fig. 38 Australia medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
• Fig. 39 South Korea medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
• Fig. 40 Latin America medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
• Fig. 41 Brazil medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
• Fig. 42 Middle East & Africa medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
• Fig. 43 Key company categorization
• Fig. 44 Strategic framework of medical footwear

Medical Footwear Market Growth & Trends:

The global medical footwear market size is anticipated to reach USD 18.28 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 11.1% from 2025 to 2030. Increasing cases of foot-related issues, ankle sprain, ulcers, diabetes, and strain and foot pain owing to obesity are expected to fuel the growth of this market. According to the American Podiatric Medical Association (APMA), in 2018, close to 81% of obese people accepted that they have witnessed foot pain and multiple foot and ankle conditions due to overweight.

The men segment led the market and accounted for 57.2% share of the global revenue in 2019. Increasing technological innovation and product launches have been driving the demand for medical footwear. For instance, in 2019, Footwear Unlimited, Inc. brand Baretraps introduced comfortable shoes with Posture+ technology that help the wearer to correct the posture and reduce strain and pressure on knees, toes, and ankle. The shoes come with a supportive heel cup and a built-in orthotic that reduces the foot pain.

The women segment is expected to register the fastest CAGR of 5.9% from 2020 to 2027. Manufacturers have been broadening their product portfolio by launching casual looking shoes for women, which is proliferating the segment growth. For instance, in July 2019, Dr. Comfort, a medical footwear brand, launched an athleisure-style shoe, The Ruth in women's category, made of full-grain leather and has reduced seam lines, protective toe box, stable outsoles, removable outsoles, and anti-abrasion material to aid durability, stability, and support.

The COVID-19 (coronavirus) outbreak has severely impacted the footwear industry, including medical footwear, with a reduction in demand owing to store closures, lockdown measures, and restriction in imports and exports at the global level. Sales data reported for Amazon between mid-February and mid-March 2020 showed footwear sales fell by an average of 40 percentage points. Consumers have become more conscious of their spending habits and tend to purchase mostly essential products, which is a major challenge for the market.

The online distribution channel is expected to witness the fastest growth over the forecast period. The rising popularity of e-commerce channels among the manufacturers and high internet penetration among millennials, Gen Z, and Gen X have been driving the sale through this channel. E-commerce websites such as Amazon, Flipkart, Orthorest, and Dr. Comfort offer discounts, deals, and new launches, which attract the consumers and fuel the segment growth.

North America dominated the market for medical footwear and accounted for 33.5% share of the global revenue in 2019. The growth of the regional market is powered by an increasing number of people witnessing foot-related issues in the region. According to a report by the American Podiatric Medical Association, 50% of Americans have limited their outdoor activities due to foot pain because of poor design shoes and high impact activities, such as jumping, running, and dancing.

Asia Pacific is expected to register the fastest CAGR of 6.1% from 2020 to 2027. Increasing cases of diabetes in the region are expected to drive the demand for medical footwear. Moreover, people in the countries, including China, India, and Japan, have become more conscious of their health and are willingly purchasing footwear that can offer relief to chronic foot pain.

Medical Footwear Market Report Highlights:

• The online distribution channel emerged as the fastest distribution channel in 2024 and is expected to maintain its lead throughout the forecast period. The increasing availability of medical footwear of different brands, free delivery, and seasonal discount on e-retailer platforms are among the major reasons fueling the segment growth
• The men segment held the largest revenue share in the medical footwear industry in 2024 due to the increasing prevalence of foot-related issues among men, such as diabetes and orthopedic conditions.
• Asia Pacific is the fastest growing regional market with a CAGR of 6.1% from 2024 to 2030. Growing awareness among people regarding the benefits of medical footwear including increased blood flow, improved mobility, and enhanced foot support is expected to drive the regional market.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources & Third-Party Perspectives
  • 1.3.4. Primary Research
• 1.4. Information Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Data Visualization
• 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Medical Footwear Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related Market Outlook
• 3.2. Industry Value Chain Analysis
  • 3.2.1. Profit Margin Analysis (Industry-level)
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
  • 3.3.2. Market Restraint Analysis
  • 3.3.3. Market Opportunities
  • 3.3.4. Market Challenges
• 3.4. Industry Analysis Tools
  • 3.4.1. Porter's Five Forces Analysis
• 3.5. Market Entry Strategies

Chapter 4. Consumer Behavior Analysis

• 4.1. Demographic Analysis
• 4.2. Consumer Trends and Preferences
• 4.3. Factors Affecting Buying Decision
• 4.4. Consumer Product Adoption
• 4.5. Observations & Recommendations

Chapter 5. Medical Footwear Market: Distribution Channel Estimates & Trend Analysis

• 5.1. Medical Footwear Market, by Distribution Channel: Key Takeaways
• 5.2. Distribution Channel Movement Analysis & Market Share, 2024 & 2030
• 5.3. Market Estimates & Forecasts, by Distribution Channel, 2018 - 2030 (USD Million)
  • 5.3.1. Offline
    • 5.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.3.2. Online
    • 5.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. Medical Footwear Market: End Use Estimates & Trend Analysis

• 6.1. Medical Footwear Market, by End Use: Key Takeaways
• 6.2. End Use Movement Analysis & Market Share, 2024 & 2030
• 6.3. Market Estimates & Forecasts, by End Use, 2018 - 2030 (USD Million)
  • 6.3.1. Men
    • 6.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.3.2. Women
    • 6.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Medical Footwear Market: Regional Estimates & Trend Analysis

• 7.1. Medical Footwear Market: Regional Outlook
• 7.2. Regional Marketplaces: Key Takeaways
• 7.3. Market Estimates & Forecasts, by region, 2018 - 2030 (USD Million)
  • 7.3.1. North America
    • 7.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.1.2. U.S.
      • 7.3.1.2.1. Key country dynamics
      • 7.3.1.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.1.3. Canada
      • 7.3.1.3.1. Key country dynamics
      • 7.3.1.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.1.4. Mexico
      • 7.3.1.4.1. Key country dynamics
      • 7.3.1.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.3.2. Europe
    • 7.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.2.2. UK
      • 7.3.2.2.1. Key country dynamics
      • 7.3.2.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.2.3. Germany
      • 7.3.2.3.1. Key country dynamics
      • 7.3.2.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.2.4. France
      • 7.3.2.4.1. Key country dynamics
      • 7.3.2.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.2.5. Italy
      • 7.3.2.5.1. Key country dynamics
      • 7.3.2.5.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.2.6. Spain
      • 7.3.2.6.1. Key country dynamics
      • 7.3.2.6.2. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.3.3. Asia Pacific
    • 7.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.3.2. China
      • 7.3.3.2.1. Key country dynamics
      • 7.3.3.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.3.3. India
      • 7.3.3.3.1. Key country dynamics
      • 7.3.3.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.3.4. Japan
      • 7.3.3.4.1. Key country dynamics
      • 7.3.3.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.3.5. Australia
      • 7.3.3.5.1. Key country dynamics
      • 7.3.3.5.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.3.6. South Korea
      • 7.3.3.6.1. Key country dynamics
      • 7.3.3.6.2. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.3.4. Latin America
    • 7.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.4.2. Brazil
      • 7.3.4.2.1. Key country dynamics
      • 7.3.4.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.3.5. Middle East & Africa
    • 7.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Medical Footwear Market: Competitive Analysis

• 8.1. Recent Developments & Impact Analysis, by Key Market Participants
• 8.2. Company Categorization
• 8.3. Participant's Overview
• 8.4. Financial Performance
• 8.5. Product Benchmarking
• 8.6. Company Heat Map Analysis
• 8.7. Strategy Mapping
• 8.8. Company Profiles
  • 8.8.1. DJO, LLC
    • 8.8.1.1. Company Overview
    • 8.8.1.2. Financial Performance
    • 8.8.1.3. Product Portfolios
    • 8.8.1.4. Strategic Initiatives
  • 8.8.2. New Balance
    • 8.8.2.1. Company Overview
    • 8.8.2.2. Financial Performance
    • 8.8.2.3. Product Portfolios
    • 8.8.2.4. Strategic Initiatives
  • 8.8.3. Dr. Zen's.
    • 8.8.3.1. Company Overview
    • 8.8.3.2. Financial Performance
    • 8.8.3.3. Product Portfolios
    • 8.8.3.4. Strategic Initiatives
  • 8.8.4. Gravity Defyer Corp.
    • 8.8.4.1. Company Overview
    • 8.8.4.2. Financial Performance
    • 8.8.4.3. Product Portfolios
    • 8.8.4.4. Strategic Initiatives
  • 8.8.5. Orthofeet Inc
    • 8.8.5.1. Company Overview
    • 8.8.5.2. Financial Performance
    • 8.8.5.3. Product Portfolios
    • 8.8.5.4. Strategic Initiatives
  • 8.8.6. Aetrex Inc.
    • 8.8.6.1. Company Overview
    • 8.8.6.2. Financial Performance
    • 8.8.6.3. Product Portfolios
    • 8.8.6.4. Strategic Initiatives
  • 8.8.7. DARCO International, Inc.
    • 8.8.7.1. Company Overview
    • 8.8.7.2. Financial Performance
    • 8.8.7.3. Product Portfolios
    • 8.8.7.4. Strategic Initiatives
  • 8.8.8. Dr. Foot Inc.
    • 8.8.8.1. Company Overview
    • 8.8.8.2. Financial Performance
    • 8.8.8.3. Product Portfolios
    • 8.8.8.4. Strategic Initiatives
  • 8.8.9. Duna
    • 8.8.9.1. Company Overview
    • 8.8.9.2. Financial Performance
    • 8.8.9.3. Product Portfolios
    • 8.8.9.4. Strategic Initiatives
  • 8.8.10. Mephisto
    • 8.8.10.1. Company Overview
    • 8.8.10.2. Financial Performance
    • 8.8.10.3. Product Portfolios
    • 8.8.10.4. Strategic Initiatives